Amgen acquires German drug

By Staff Report  /  Thursday, September 1st, 2016  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen acquires German drug

Story updated at 11 a.m.: Thousand Oaks-based biotech giant Amgen acquired global development rights to a multiple myeloma drug from a German company Sept. 1. Amgen said in a news release it acquired commercial and development rights to BI 836909, which is currently being developed by German company Boehringer Ingelheim. It will work with Boehringer Read More →